New data further validate FirstLook Lung cancer screening test, highlight the broad potential of DELFI’s fragmentomic-based approach in early cancer detection and treatment monitoring PALO ALTO, Calif. and BALTIMORE, April 1, 2024 /PRNewswire/ — DELFI Diagnostics, Inc., a developer of…